Toshio Akiyama
Concepts (109)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Pacemaker, Artificial | 6 | 1989 | 29 |
Why?
|
Anti-Arrhythmia Agents | 7 | 1994 | 36 |
Why?
|
Arrhythmias, Cardiac | 6 | 1990 | 65 |
Why?
|
Tachycardia, Ventricular | 4 | 1992 | 25 |
Why?
|
Long QT Syndrome | 3 | 1989 | 35 |
Why?
|
Atrioventricular Node | 1 | 2010 | 8 |
Why?
|
Heart Conduction System | 3 | 1989 | 37 |
Why?
|
Cardiology | 1 | 2010 | 25 |
Why?
|
Phenethylamines | 1 | 2007 | 17 |
Why?
|
Torsades de Pointes | 1 | 2007 | 16 |
Why?
|
Sulfonamides | 1 | 2007 | 74 |
Why?
|
Electrocardiography | 8 | 1989 | 132 |
Why?
|
Automobile Driving | 2 | 2001 | 19 |
Why?
|
Atrial Fibrillation | 4 | 1989 | 40 |
Why?
|
Encainide | 2 | 1991 | 2 |
Why?
|
Flecainide | 2 | 1991 | 8 |
Why?
|
Myocardial Infarction | 6 | 1989 | 129 |
Why?
|
Accidents, Traffic | 2 | 2001 | 48 |
Why?
|
Syncope, Vasovagal | 1 | 2000 | 5 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2000 | 13 |
Why?
|
Tachycardia, Supraventricular | 1 | 2000 | 14 |
Why?
|
Heart Block | 4 | 1989 | 30 |
Why?
|
Aging | 2 | 1992 | 275 |
Why?
|
Moricizine | 2 | 1991 | 2 |
Why?
|
Cardiac Complexes, Premature | 2 | 1991 | 9 |
Why?
|
Humans | 20 | 1989 | 1856 |
Why?
|
Defibrillators, Implantable | 5 | 1996 | 35 |
Why?
|
Death, Sudden, Cardiac | 1 | 1996 | 31 |
Why?
|
Aged | 11 | 1989 | 988 |
Why?
|
Middle Aged | 8 | 1991 | 1161 |
Why?
|
Pregnancy Complications, Cardiovascular | 1 | 1992 | 28 |
Why?
|
Female | 13 | 1989 | 1643 |
Why?
|
Magnesium | 1 | 1992 | 69 |
Why?
|
Follow-Up Studies | 7 | 1989 | 553 |
Why?
|
Heart Arrest | 1 | 1991 | 37 |
Why?
|
Male | 10 | 1989 | 1553 |
Why?
|
Germany | 1 | 2010 | 21 |
Why?
|
Japan | 1 | 2010 | 25 |
Why?
|
Risk Factors | 4 | 1991 | 555 |
Why?
|
Equipment Failure | 2 | 1998 | 44 |
Why?
|
Hypocalcemia | 1 | 1989 | 12 |
Why?
|
Tachycardia | 1 | 1989 | 32 |
Why?
|
History, 20th Century | 1 | 2010 | 111 |
Why?
|
Electric Power Supplies | 1 | 2007 | 5 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 1996 | 176 |
Why?
|
Equipment Design | 1 | 2007 | 132 |
Why?
|
Aged, 80 and over | 3 | 1989 | 599 |
Why?
|
Ventricular Fibrillation | 1 | 2004 | 24 |
Why?
|
Time Factors | 2 | 2002 | 896 |
Why?
|
Dizziness | 1 | 2001 | 10 |
Why?
|
Heart Rate | 1 | 2004 | 138 |
Why?
|
Syncope | 1 | 2001 | 24 |
Why?
|
Retrospective Studies | 1 | 2007 | 653 |
Why?
|
Heart Ventricles | 2 | 1989 | 86 |
Why?
|
Risk | 1 | 2001 | 203 |
Why?
|
Amiodarone | 2 | 1994 | 10 |
Why?
|
United States | 2 | 1991 | 604 |
Why?
|
Stroke Volume | 2 | 1992 | 54 |
Why?
|
Drug Therapy, Combination | 2 | 1992 | 189 |
Why?
|
Cardiovascular Agents | 1 | 1996 | 18 |
Why?
|
Multicenter Studies as Topic | 1 | 1996 | 70 |
Why?
|
Adult | 3 | 1992 | 1317 |
Why?
|
Questionnaires | 1 | 2001 | 360 |
Why?
|
Hypertension | 2 | 1991 | 161 |
Why?
|
Guidelines as Topic | 1 | 1994 | 77 |
Why?
|
Magnesium Sulfate | 1 | 1992 | 10 |
Why?
|
Spondylitis, Ankylosing | 1 | 1991 | 11 |
Why?
|
Furosemide | 1 | 1991 | 18 |
Why?
|
Diet, Sodium-Restricted | 1 | 1991 | 13 |
Why?
|
Drug Combinations | 1 | 1991 | 95 |
Why?
|
Placebos | 1 | 1991 | 110 |
Why?
|
Diabetes Complications | 1 | 1991 | 49 |
Why?
|
Cause of Death | 1 | 1991 | 82 |
Why?
|
Alcoholism | 1 | 1991 | 51 |
Why?
|
Heart Valve Diseases | 1 | 1990 | 18 |
Why?
|
Child | 1 | 2000 | 749 |
Why?
|
Sick Sinus Syndrome | 1 | 1990 | 5 |
Why?
|
Logistic Models | 1 | 1992 | 251 |
Why?
|
Age Factors | 1 | 1992 | 480 |
Why?
|
Prognosis | 1 | 1992 | 388 |
Why?
|
Activities of Daily Living | 1 | 1989 | 122 |
Why?
|
Pregnancy | 1 | 1992 | 455 |
Why?
|
Digoxin | 1 | 2004 | 12 |
Why?
|
Cardiac Output | 1 | 2004 | 48 |
Why?
|
Calcium Channel Blockers | 1 | 2004 | 48 |
Why?
|
Confidence Intervals | 1 | 2004 | 104 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2004 | 47 |
Why?
|
North America | 1 | 2003 | 19 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2004 | 23 |
Why?
|
Catheter Ablation | 1 | 2004 | 38 |
Why?
|
Europe | 1 | 2003 | 54 |
Why?
|
Multivariate Analysis | 1 | 2004 | 225 |
Why?
|
Case-Control Studies | 1 | 2004 | 283 |
Why?
|
Survival Rate | 1 | 2004 | 250 |
Why?
|
Psychomotor Performance | 1 | 2003 | 69 |
Why?
|
Cost-Benefit Analysis | 1 | 2002 | 118 |
Why?
|
Survivors | 1 | 2002 | 45 |
Why?
|
Coronary Disease | 1 | 2004 | 94 |
Why?
|
Length of Stay | 1 | 2002 | 166 |
Why?
|
Ambulatory Care | 1 | 2002 | 106 |
Why?
|
Cohort Studies | 1 | 2004 | 332 |
Why?
|
Survival Analysis | 1 | 2002 | 205 |
Why?
|
Hospitalization | 1 | 2002 | 169 |
Why?
|
Tetralogy of Fallot | 1 | 1998 | 12 |
Why?
|
Treatment Outcome | 1 | 2004 | 661 |
Why?
|
Swine | 1 | 1989 | 95 |
Why?
|
Ischemic Attack, Transient | 1 | 1989 | 28 |
Why?
|
Life Style | 1 | 1989 | 55 |
Why?
|
Animals | 1 | 1989 | 1031 |
Why?
|
